Client News

Mainz Biomed to Attend 2025 Maxim Growth Summit 

Andera Partners Reinvests in Tubulis’ €308 million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline

QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim to address high unmet needs in cancer patients

Together We Build: Rentschler Biopharma celebrates construction progress of new buffer media facility, largest single investment at Laupheim site

Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025

Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

Heidelberg Pharma AG Announces Updated Guidance

Rentschler Biopharma further expands its services in Japan and South Korea and will attend BioProcess International Asia

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data